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Abstract
Photodynamic therapy (PDT) is a
clinically approved procedure for targeting
tumor cells. Though several different pho-
tosensitizers have been developed, there is
still much demand for novel photosen-
sitizers with improved properties. In
this study we aim to characterize the
accumulation, localization and dark
cytotoxicity of the novel photosensitizers developed in-house derivatives of
porphyrazines (pz I-IV) in primary murine neuronal cells, as well as to identify the
concentrations at which pz still effectively induces death in glioma cells yet is non-
toxic to nontransformed cells. The study shows that incubation of primary neuronal
and glioma cells with pz I-IV leads to their accumulation in both types of cells, but
their rates of internalization, subcellular localization and dark toxicity differ signif-
icantly. Pz II was the most promising photosensitizer. It efficiently killed glioma
cells while remaining nontoxic to primary neuronal cells. This opens up the possi-
bility of evaluating pz II for experimental PDT for glioma.
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1 | INTRODUCTION
Malignant gliomas are the most common type of primary
brain tumors. They represent one of the worst types of human
cancers, with one of the poorest 5-year overall survival rates
among all human cancers [1, 2]. Importantly, current multi-
modal treatment for gliomas (eg, chemotherapy, targeted ther-
apy, radiotherapy) fails to improve prognosis, which prompted
scientists to look for novel means of treating this disease. The
difficulty in developing new treatment modalities for gliomas
is that the brain tissue adjacent to the tumor must be preserved
and damage to the nontransformed brain tissues must be mini-
mized, even when micro metastases are present, because of the
generally high sensitivity of normal brain tissue to most physi-
cal and chemical treatment agents [3].
Photodynamic therapy (PDT) is a clinically approved,
minimally invasive, multistep procedure that uses the toxicity#Maria V. Vedunova and Dmitri V. Krysko share senior authorship.
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of singlet oxygen (1O2) and other reactive oxygen species
generated by a reaction between a highly safe photosensitizer
accumulated in tumor cells and a light with a specific wave-
length corresponding to an absorbance band of the photosensi-
tizer it excites [4]. Although several different photosensitizers
or their precursors, including the hematoporphyrin derivatives
porfimer sodium, temoporfin, verteporfin and 5-ALA, have
been used clinically to treat different brain tumors, including
high grade gliomas [5–7], there is still a need for new photo-
sensitizers with improved properties but low cytotoxicity
for nontransformed brain tissues. Porphyrazines (pz) or
tetracyanoporphyrazines, which are tetrapyrrole macrocycles
similar to porphyrins and phthalocyanines, have recently
emerged as a useful class of photosensitizers suitable for PDT
and with excellent uptake and retention properties [8, 9]. Pz
differ from porphyrins in that they contain meso nitrogen atoms
rather than carbon atoms and differ from phthalocyanines
because their β-pyrrole positions are open for substitution.
These differences confer physical properties that are distinct
from those of porphyrins and phthalocyanines [10].
Recently, several novel pz photosensitizers with cyano
and aryl substituents in the periphery of the tetrapyrrole
macrocycle have been described [8, 11, 12]. The unique fea-
ture of the cyanoarylporphyrazines (hereafter referred to as
pz) is that their photophysical properties are highly sensitive
to the viscosity of the medium. It has been shown that pz
with para-fluorophenyl groups possess properties that
enable their dual use as sensitizers as well as viscosity
markers in PDT, thus providing a new type of diagnostic
and dosimetry tool in PDT treatment [8]. Moreover, the pho-
todynamic properties of pz can be significantly improved by
chemical design of the peripheral aryl groups [13, 14]. In his
study, we analyzed four cyanoarylporphyrazines (pz I-IV;
Figure 1A) that are highly potent in PDT.
Administration of photosensitizers and subsequent PDT
can damage normal neurons and glial cells, leading to
unwanted neurological consequences [15]. This dictates the
need to compare the effects of photosensitizers on these cells
and on cancer glioma cells. Therefore this study has two
aims. First, it aims to characterize the accumulation, locali-
zation and dark cytotoxicity of the novel photosensitizers we
developed in-house from groups I-IV of pz (Figure 1A) in
primary murine neuronal cells. Second, it aims to analyze
the concentrations at which pz I-IV are effective in inducing
cell death in glioma cells but are nontoxic to nontransformed
neuronal cells. This knowledge will allow us to select the
safest pz for future experimental PDT of brain cancer.
2 | MATERIALS AND METHODS
2.1 | Ethics statement
All experiments were approved by the Bioethics Committee
of Lobachevsky University and carried out in accordance
with Act708n (23 082010) of the Russian Federation
National Ministry of Public Health, which states the rules of
laboratory practice for the care and use of laboratory ani-
mals, and Council Directive 2010/63 EU of the European
Parliament (September 22, 2010) on the protection of ani-
mals used for scientific purposes. C57BL/6J mice were
killed by cervical vertebra dislocation, their embryos were
surgically removed, and then they were decapitated.
2.2 | Isolation of the primary neuronal
cultures
Primary cells were obtained from the cerebral cortex of
embryos obtained from C57BL/6J mice (day 18 of gestation)
and cultured on coverslips (18 × 18 mm) pretreated with
polyethyleneimine solution (1 mg/mL; Sigma-Aldrich,
P3143) according to a previously developed protocol [16].
In brief, after surgical isolation, embryonic cerebral cortices
were mechanically dissected in PBS followed by incubation
for 20 minutes in 0.25% trypsin-ethylenediaminetetraacetic
acid (EDTA, Invitrogen, 25200-056). The suspension of dis-
sociated cells was centrifuged at 1000 rpm for 3 minutes,
FIGURE 1 A chemical structure and absorption spectra of pz I-IV. A, Chemical structure of tetra(4-fluorophenyl)tetracyanoporphyrazines. B,
Absorbance and fluorescence spectra of photosensitizers obtained by spectrofluorometry. As pz I-IV showed very weak fluorescence in water, the
pz I-IV fluorescence was analyzed in an ethanol/glycerol mixture with a viscosity of about 45 cP. All four compounds have a red emission
(640-660 nm). pz II showed the strongest long-wave fluorescence and pz IV the strongest shortwave fluorescence
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and the pellet was resuspended in Neurobasal medium
(Invitrogen, 21103-049) supplemented with 2% B27
(Invitrogen, 17504-044), 0.5 mM L-glutamine (Invitrogen,
25030-024), and 5% fetal bovine serum (FBS; PanEco,
K055, Russia). The suspension was placed on coverslips at
an initial density of 4500 cells/mm2. Half of the medium
containing 0.4% of FBS was replaced every third day.
2.3 | Glioma cell line
Murine glioma GL261 cells were cultured at 37!C under 5%
CO2 in DMEM containing 4.5 g/L glucose and sup-
plemented with 2 mM glutamine, 100 μM sodium pyruvate,
100 U/mL penicillin, 100 μg/L streptomycin and 10% FBS
(Fisher Scientific, 10082147). At the end of the exponential
growth period, the cells were removed using a solution of
trypsin-versine (1:3) and reseeded. The multiplicity of
seeding was 1:10, and the cell density was 1.0 × 105 cells/mL.
Experiments were carried out after the third passage. The
viability of primary neuronal cultures and GL261 glioma
cells was maintained at 35.5!C under 5% CO2 in a humid-
ified atmosphere in a cell culture incubator (Sheldon
Manufacturing).
2.4 | Spectra acquisition
This study used cyanoarylporphyrazines with 9-phenanthrenyl
(pz I), 4-biphenyl (pz II), 4-(4-fluorobenzyoxy)phenyl (pz III)
and 4-diethylaminophenyl (pz IV) groups in the aryl frame of
the macrocycle (Figure 1A). Absorption and fluorescence spec-
tra of pz I-IV were registered using Synergy MX Microplate
Reader (BioTek) in black 96-well microplates with a clear glass
bottom (Falcon Imaging; Corning). Fluorescence was excited
at 590 nm. Since the fluorescence quantum yield of pz I-IV in
nonviscous media is very low, the fluorescence was measured
in ethanol-glycerol solution (2:3).
2.5 | Analysis of dark cytotoxicity in primary
neuronal cultures
To estimate the dark toxicity effects, the photosensitizers
were added to the culture medium on day 14 of the primary
neuronal culture development at concentrations of 0.1, 1, 10,
50 and 100 μM. Then, the cell cultures were placed in a CO2
incubator in the dark.
Cell culture viability was evaluated on days 3 and 7 after
pz I-IV application. Viability was calculated as the number
of dead cells stained with propidium iodide (PI) (Sigma-
Aldrich, P4170) relative to the total number of cells stained
with bisbenzimide (Invitrogen, H3570) [17]. PI binds to
double-stranded DNA by intercalating between base pairs,
but it is excluded from cells with intact plasma membranes
(ie, viable cells). PI and bisbenzimide were added to the cul-
ture medium to final concentrations of 5 and 1 mg/mL,
respectively, 30 minutes before assessing viability. The cul-
tures stained with fluorescent dyes were observed using a
Leica DMIL HC inverted fluorescence microscope (Leica,
Germany) with a 10x/0.2Ph1 objective.
2.6 | Analysis of cell death by MTT assay
Cell death was induced by PDT after treatment of the cells
with pz I, pz II, pz III, or pz IV. GL261 glioma cells were
seeded in 96-well glass-bottom plates (Corning) at 6 × 103
cells per well and grown overnight. The glioma cells were
then incubated with the different pz photosensitizers in
serum-free medium at concentrations ranging from 0.001 to
70 μM for 4 hours, followed by irradiation with a light dose
of 20 J/cm2 in photosensitizer-free medium using a LED
light source at a power density of 20 mW/cm2 (λex
615–635 nm) [18]. Cells loaded with the different photosensi-
tizers were handled either in the dark or in subdued light. After
PDT, the cells were cultured in complete medium for 24 hours
and cell death was analyzed by MTT assay (Alfa Aesar,
L11939.06) according to the manufacturer's instructions. Opti-
cal density was measured at 570 nm. Control cells were cul-
tured in the same conditions but without photosensitizers.
2.7 | Accumulation dynamics and subcellular
distribution of pz
To analyze accumulation dynamics, GL261 cells were
seeded in 96-well glass-bottom plates (Corning) at 104 cells
per well and grown overnight. Then, the cells were incu-
bated with 10 μM of the different photosensitizers in serum-
free culture medium for 2 to 4 hours, followed by washing
with PBS and confocal image acquisition. The same was
done for primary neuronal cultures.
Due to the complex morphology of primary neuronal cul-
tures, we used a fluorescent calcium-sensitive dye (Oregon
Green 488 BAPTA-1AM “OGB1”; Invitrogen, O-6807).
This dye reveals the cytoplasm of neurons and glial cells
and makes it possible to track the accumulation of pz I-IV
even in the thinnest outgrowths of nerve cells [19]. OGB1
(0.4 mM) was added to the culture medium 40 minutes
before confocal image acquisition. OGB1 was excited at
488 nm and emission was recorded in the range of 500 to
530 nm. The fluorescence of pz I-IV was excited at 594 nm
and recorded in the range of 600 to 670 nm.
For colocalization analysis of pz I-IV, the following dyes
(all from Thermo Fisher Scientific) were added for 30 minutes:
0.5 μM LysoTracker Green DND-26 (L7526), 0.5 μM
ER-Tracker (E34251) and 0.5 μM MitoTracker Green FM
(M7514). The fluorescent dyes were added to the viable cells
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after their incubation with the different photosensitizers (pz I-
IV). The cells were stained according to the manufacturer's
instructions. Fluorescence of the stained organelles was excited
by an argon laser at 488 nm and registered in the range of
500 to 560 nm.
Intracellular distribution of pz I-IV was studied by
using the LSM 710 Axio Obzerver Z1 DUO NLO laser
scanning microscope (Carl Zeiss, Germany). The images
were obtained using an LD C-Apochromat water immer-
sion objective lens 40×/1.1.
2.8 | Statistical analysis
Statistical analysis was performed in GraphPad Prism
(v.6.0). Cell death was analyzed by ANOVA followed by t-
criteria with Bonferroni correction.
3 | RESULTS AND DISCUSSION
3.1 | Spectra characterization
First, we analyzed the absorption and fluorescence spectra of pz
I-IV, which belong to the family of tetra(aryl)tetra(cyano)
porphyrazines (Figure 1A). The absorption peaks of pz I-IV in
aqueous solution were all in the shortwave region (Soret band)
and the long-wave region (Q-band) of the spectrum (Figure 1B).
Some bathochromic shift of Q-band that we observed for pz II
and even more for pz III is due to the contribution of the addi-
tional peripheral aryl substituent to the total π-conjugated aro-
matic system of the macrocycle. The value of this contribution
depends on the aromatic system length, its geometry and the
angle which the aryl substituent forms with the macrocyclic ring
plane.
It should be noted that pz I-IV belong to the class of
“molecular rotors,” and their fluorescence depends on the
rate of intramolecular rotation [8]. Intramolecular rotation is
found to be the main nonradiative way of the excited state
relaxation for “molecular rotors” in the environment of low
viscosity. Thus, pz I-IV showed very weak fluorescence in
water (data not shown). But the fluorescence intensity of
those dyes increased very strongly in the environment of
high viscosity because viscous media prevent segmental
intermolecular mobility. Therefore, we analyzed the pz I-IV
fluorescence in an ethanol/glycerol mixture with a viscosity
of about 45 cP (Figure 1B). All four compounds have a red
emission (640–660 nm). Porphyrazine with peripheral
biphenyl groups (pz II) showed the strongest long-wave
fluorescence and pz IV with diethylamino group at para-
position of the phenyl substituent demonstrated stronger
shortwave fluorescence.
FIGURE 2 Uptake of pz I-IV by primary neuronal cells. Cellular uptake was assessed by confocal microscopy after 2 hours, A and 4 hours, B
of incubation with the different pz I-IV (5 μM) on day 14 of culture development in vitro. Green channel: primary cultures were prestained with
Oregon Green 488 BAPTA-1 AM (OGB1) to visualize the cytoplasm of neurons and glial cells in the culture. Red channel: fluorescence of
photosensitizer. Merged: overlay of the fluorescence channels. Scale bars, 50 μm. C, The fluorescence intensity (Ifl) of the cells after incubation with
the pz I-IV. Of note, all four photosensitizers were substantially present in neurons and glial cells in primary cultures 2 hours after pz I-IV addition.
It is assumed that the size and hydrophobicity of the molecule are important determinants of the rate of dye penetration through the plasma
membrane. Pz IV, being the most compact molecule, had the highest internalization rate
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3.2 | Cellular uptake and subcellular
localization of pz I-IV in GL261 glioma cells
and primary neuronal cells
We used confocal microscopy to analyze the rate of uptake
of pz I-IV into primary neuronal cells and GL261 glioma
cells. First, we analyzed the rate of pz I-IV accumulation
into primary neuronal cells. We found that all four photosen-
sitizers were substantially present in neurons and glial cells
in primary cultures 2 hours after pz I-IV addition (Figure 2).
The size and hydrophobicity of the molecule seem to be the
important determinants of the rate of dye penetration through
the plasma membrane. Pz IV, as the most compact mole-
cule, had the highest internalization rate. Analysis of the
subcellular localization of pz I-IV revealed that all four pz
accumulated in vesicles, mostly in lysosomes (Figure 3),
whereas the most hydrophobic (pz I and pz II) were
detected in the endoplasmic reticulum as well. Importantly,
it has been shown that subcellular localization of photosensi-
tizers in the endoplasmic reticulum could indicate their abil-
ity to induce an immunogenic form of cancer cell death
[20–23]. Next, we found that incubation of GL261 glioma
cells for 2 hours with any of the four photosensitizers was
sufficient for accumulation of a substantial amount of pz in
the cells (Figure 4A), suggesting that use of these pz in PDT
will effectively kill GL261 glioma cells. Notably, pz I and
pz IV had the highest internalization rate. The difference
between neurons and glioma cells may be due to a signifi-
cant difference in the relative contributions of the internali-
zation pathways in these types of cells.
3.3 | Analysis of the dark toxicity of pz I-IV in
primary neuronal cultures
A basic requirement for development of PDT for gliomas is
determination of the photosensitizer concentrations that can
effectively kill cancer glioma cells without being toxic to
native (nontumor or nontransformed) cells. The reason is
that a photosensitizer delivered to a tumor during PDT will
also reach intact cells in its vicinity. Moreover, photosensi-
tizers may possess dark toxicity (ie, light-independent toxic-
ity), which can limit their use in vivo [24]. Therefore, we
analyzed the dark cytotoxicity of the newly synthesized pz
I-IV photosensitizers for primary neuronal cultures to allow
FIGURE 3 Subcellular distribution of pz I-IV in primary neuronal cells. Analysis was done 2 hours after the start of incubation with the
different photosensitizers. The following dyes were used: LysoTracker Green (DND-26) for lysosomes; MitoTracker Green for mitochondria; ER-
Tracker for ER. In graphs: red line—fluorescence intensity of photosensitizer; green line—fluorescence intensity of dye in the indicated cellular
compartment (Ifl, a.u. ×103). All four pz accumulated in vesicles, mostly in lysosomes, and the most hydrophobic (pz I and pz II) were detected in
the endoplasmic reticulum as well. Scale bars, 20 μm
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us to estimate possible toxic effects of pz I-IV and to select
the most suitable photosensitizer for PDT of glioma. The
cytotoxic effects of photosensitizers in the short time frame
are of low interest, because the cells of the central nervous
system are characterized by certain patterns of neural net-
work degradation [25]. Therefore, to analyze the cytotoxic
effects, we selected two principal time points for assessment
of delayed cytotoxicity, namely, days 3 and 7. Day 3 after
addition of the photosensitizer reflects the period of a pri-
mary wave of cell death resulting from the direct cytotoxic
effect of the photosensitizer on neuronal cells. In contrast,
day 7 after incubation with the photosensitizer is character-
ized by the second wave of cell death due to the loss of a
considerable quantity of neuronal intercommunications [3].
In our previous work, we have shown that the number of the
dead cells reaches maximum on day 7 [25]. Analysis of the
dark cytotoxicity of pz I-IV showed that high concentrations
of the photosensitizers have a strong cytotoxic effect on pri-
mary neuronal cells (Figure 5). On the seventh day after
addition of 100 μM of the pz to the primary neuronal cells,
the following percentages of dead cells were found
(Figure 5): pz I, 98% ± 1.21%; pz II, 95.9% ± 3.54%, pz
III, 97.65% ± 3.65%; pz IV, 87.39% ± 2.06%. Even 10-fold
lower concentration of the photosensitizers (10 μM) had a
pronounced cytotoxic effect on the primary neuronal cells.
The fraction of dead primary neuronal cells on the seventh
day exceeded 30% (Figure 5): pz I, 30.09% ± 7.68%; pz II,
35.63% ± 3.00%; pz III, 60.45% ± 5.04%; pz IV, 55.78%
± 3.74%. However, 0.1 μM of pz I or pz IV did not have a
pronounced cytotoxic effect on primary neuronal cells. The
viability of the cells in the experimental groups was compa-
rable to that of untreated cells. Notably, addition of the same
concentration of pz II or pz III had a somewhat lower cyto-
toxic effect, but it was significant relative to the absence of
treatment. The percentages of dead cells were 10.63%
± 1.55 for pz II, 11.41% ± 1.66 for pz III, and 4.51%
± 0.49 in the nontreated cultures. Analysis of dark cytotox-
icity revealed that though the four photosensitizers have sim-
ilar chemical structures, they have relatively different
cytotoxicities for primary neuronal cells. Of note, the cyto-
toxic effect does not strictly correlate with the rate of pz
uptake. While pz I and pz III had the lowest internalization
rates, through this analysis we identified pz I and pz II as
having the lowest dark cytotoxicity for nontransformed pri-
mary neuronal cells. Other factors, including localization,
potential interference with metabolic pathways, and steric
interaction with biological macromolecules, are assumed to
be important. A low dark toxicity of photosensitizers is
FIGURE 4 Analysis of the interaction of pz I-IV with GL261 glioma cells. A, Representative confocal images and fluorescence intensities (Ifl)
of glioma GL261 cells 2 and 4 hours after incubation with pz I-IV (10 μM). Scale bars, 20 μm. Fluorescence intensity before addition of the
photosensitizers did not exceed 300 a.u. Two hours of incubation with any of the four photosensitizers was sufficient for accumulation of a
substantial amount of pz in the cells. Pz I and pz IV had the highest internalization rate. B, MTT analysis of GL261 glioma cell death after PDT.
Dark toxicity (black lines) was analyzed after incubation of GL261 glioma cells with the photosensitizers in serum-free medium for 24 hours. For
photoinduced toxicity (red lines), GL261 glioma cells were first incubated with the respective pz (I-IV) in serum-free medium for 4 hours and then
exposed to light: λex 615-635 nm, 20 J/cm2. MTT assays were performed 24 hours after irradiation. The data represent the mean values ± SD
(n = 3). Pz I-III showed no dark toxicity up to 30 μM and pz IV up to 10 μM. Analysis of phototoxicity allowed determination of the IC50 values,
which are presented for the four pz in Table 1
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especially important when they are used in vivo. In this con-
text, it has been shown that intratumoral injection of large
amounts of a hematoporphyrin derivative into rat brain
induced strong dark toxicity in normal brain while tumors
seemed unaffected [26].
3.4 | Comparative analysis of dark toxicity
and phototoxicity effects of pz I-IV
For PDT to have minor side effects, the photosensitizer
should have minimal dark cytotoxicity for normal neuronal
cells but a pronounced therapeutic effect after PDT at the
same concentration. We examined the possibility of induc-
ing cell death in the murine glioma cell line, GL261. The
FIGURE 5 Dark cytotoxicity of pz I-IV to primary neuronal cells. Analysis was performed after incubating the cells with the different
photosensitizer for 3 and 7 days. High concentrations (more than 10 μM) of pz I-IV had a strong cytotoxic effect on primary neuronal cells. The
fraction of dead cells on day 7 after starting incubation with different pz exceeded 30%. pz I and pz II had the lowest dark cytotoxicity. A low dark
toxicity of photosensitizers for nontumor cells is especially important when they are used in vivo. The data represent the mean values ± SEM from
three independent experiments. Statistical significance was calculated by using ANOVA test, *P < .05
TABLE 1 Comparison of dark cytotoxicity in primary neuronal
cultures with the IC50 phototoxicity effect of GL261 glioma cells
Photosensitizer
IC50 for GL261,
μM [95% confidence
interval]
Dark cytotoxicity for
the primary neuronal
cultures in the area of
IC50 of GL261
pz I 1.18 [0.92; 1.51] 2—Average
pz II 0.56 [0.44; 0.70] 1—Light
pz III 0.54 [0.31; 0.92] 3—Significant
pz IV 0.39 [0.29; 0.50] 2—Average
TABLE 2 Cytotoxicity score according to the ISO 10993-5:2009
Scale of
cytotoxicity
Number of
dead cells, %
Interpretation
of cytotoxicity
0 0% to 10% Not-cytotoxic
1 10% to 20% Light
2 20% to 30% Average
3 More than 30% Significant
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cells were pretreated for 4 hours with the different pz photo-
sensitizers and then irradiated with a light dose of 20 J/cm2
using a LED light source (power density of 20 mW/cm2, λex
615–635 nm). The control GL261 cells were incubated in
the dark with the same doses of photosensitizers for 28 hours
(4 + 24). Pz I-III showed no dark toxicity up to 30 μM and
pz IV up to 10 μM. (Figure 4B). Irradiation with 20 J/cm2
resulted in cell death at photosensitizer concentrations not
exceeding ~1 μM (Figure 4B). The IC50 values for the four
pz are shown in Table 1.
Next, the IC50 concentrations of pz I-IV in GL261 cells
(when irradiated at a dose of 20 J/cm2) were correlated to
their IC50 concentrations in dark toxicity (ie, without PDT)
on the primary neuronal cultures (Table 1). For this analy-
sis, we used a cytotoxicity score according to ISO
10993-5:2009 (https://www.iso.org/standard/36406.html)
(Table 2). Of the four pz, pz II had the lowest cytotoxicity
for primary neuronal cells (IC50 = 0.56 μM; Table 1). Pz I
and pz IV had IC50 of 1.18 and 0.39 μM, respectively, and
at these concentrations they had an average cytotoxicity on
primary neuronal cells (Table 1). In contrast, pz III had
the highest cytotoxicity for primary neuronal cultures
(IC50 = 0.54 μM; Table 1). This analysis demonstrated that
pz II is the most promising photosensitizer, as it can effi-
ciently kill GL261 glioma cells without being toxic for pri-
mary neuronal cells.
4 | CONCLUSIONS
Ideally, a photosensitizer should easily penetrate through
the hemato-encephalic barrier and not be absorbed in sig-
nificant amounts in healthy tissues, and it should have
maximal cytotoxic effect on malignant cells but no sys-
temic toxic effects [4]. The risks of adverse reactions and
death of healthy neuronal cells associated with the cur-
rently known photosensitizers dictate the need for new
photosensitizers that better match the requirements described
above. In that context, we comparatively studied the effects
of cyanoarylporphyrazines with 9-phenanthrenyl (pz I),
4-biphenyl (pz II), 4-(4-fluorobenzyoxy)phenyl (pz III) and
4-diethylaminophenyl (pz IV) groups in the aryl frame of the
macrocycle on primary neuronal cultures and tumor glioma
cells. We have shown that during 4 hours of incubation with
pz I-IV, all four pz accumulated in primary neuronal cells
and in glioma cells, but to different extents. These four photo-
sensitizers differ significantly in the rate of their internaliza-
tion, subcellular localization and dark toxicity. Our results
demonstrate that pz II is the most promising photosensi-
tizer, efficiently killing GL261 cells but showing no toxic-
ity to primary neuronal cells. This finding opens up
prospects for testing pz II in PDT of glioma in experimen-
tal therapy in the future.
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